NDC 66993-822-30
pioglitazone and glimepiride 4 mg/1
pioglitazone and glimepiride · TABLET
This medication combines two diabetes drugs—pioglitazone (a thiazolidinedione) and glimepiride (a sulfonylurea)—to help lower blood sugar in people with type 2 diabetes. It works by improving insulin sensitivity and stimulating the pancreas to release more insulin.
Key Facts
- Brand Name
- pioglitazone and glimepiride
- Generic Name
- pioglitazone and glimepiride
- NDC Code (Package)
66993-822-30- NDC Code (Product)
66993-822- Manufacturer
- Prasco Laboratories
- Strength
- 4 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA021925
- Drug Class
- Sulfonylurea [EPC]
- Marketing Start
- 08/04/2015
Recall History
No Recall HistoryView Full Drug Page
pioglitazone and glimepiride — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.